###begin article-title 0
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
ETS-1 and ETS-2 are upregulated in a transgenic mouse model of pigmented ocular neoplasm
###end article-title 0
###begin p 1
The first two authors contributed equally to this work.
###end p 1
###begin p 2
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin title 3
Purpose
###end title 3
###begin p 4
###xml 72 77 <span type="species:ncbi:9606">human</span>
###xml 95 100 <span type="species:ncbi:10090">mouse</span>
###xml 111 116 <span type="species:ncbi:9606">human</span>
###xml 193 198 <span type="species:ncbi:10090">mouse</span>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
###xml 368 373 <span type="species:ncbi:9606">human</span>
Choroidal melanoma is the most common primary malignant ocular tumor in human adults. Relevant mouse models of human uveal melanoma still remain to be developed. We have studied the transgenic mouse strain, Tyrp-1-TAg, to try to gain insight into possible molecular mechanisms common to pigmented ocular neoplasms occurring spontaneously in the eyes of these mice and human choroidal melanoma. The role of two members of the ETS (E26 avian leukemia oncogene) family of transcription factors, ETS-1 and ETS-2, has been investigated in many cancers but has not yet been studied in ocular tumors.
###end p 4
###begin title 5
Methods
###end title 5
###begin p 6
###xml 70 75 70 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 80 85 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 393 398 393 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 403 408 403 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 161 167 <span type="species:ncbi:10090">murine</span>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
###xml 575 580 <span type="species:ncbi:10090">mouse</span>
###xml 639 643 <span type="species:ncbi:10090">mice</span>
This is the first study describing the production and distribution of ETS-1 and ETS-2 mRNAs and proteins using in situ hybridization and immunohistochemistry in murine ocular tissue sections of normal control eyes and tumoral eyes from mice of the same age. Using semi-quantitative reverse-transcription polymerase chain reaction (RT-PCR) and western blots experiments, we compared changes in ETS-1 and ETS-2 expression, their protein levels, and the regulation of some of their target gene expressions at different stages of the ocular tumoral progression in the transgenic mouse model, Tyrp-1-TAg, with those in normal eyes from control mice of the same age.
###end p 6
###begin title 7
Results
###end title 7
###begin p 8
###xml 292 297 292 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 302 307 302 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 536 541 536 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 546 551 546 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
###xml 385 389 <span type="species:ncbi:10090">mice</span>
###xml 436 440 <span type="species:ncbi:10090">mice</span>
###xml 585 589 <span type="species:ncbi:10090">mice</span>
###xml 649 653 <span type="species:ncbi:10090">mice</span>
In normal control adult mouse eyes, ETS-1 was mostly present in the nuclei of all neuroretinal layers whereas ETS-2 was mostly localized in the cytosol of the cell bodies of these layers with a smaller amount present in the nuclei. Both were found in the retinal pigmentary epithelium (RPE). ETS-1 and ETS-2 mRNA and protein levels were much higher in the ocular tissues of Tyrp-1-TAg mice than in control ocular tissues from wild-type mice. This upregulation was correlated with tumor progression. We also demonstrated upregulation of ETS-1 and ETS-2 target expressions in Tyrp-1-TAg mice when comparing with the same target expressions in control mice.
###end p 8
###begin title 9
Conclusions
###end title 9
###begin p 10
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
Our findings suggest that ETS-1 and ETS-2 are upregulated in ocular tumors derived from the retinal epithelium and may be involved in one or several signaling pathways that activate the expression of a set of genes involved in ocular tumor progression such as those encoding ICAM-1 (intercellular adhesion molecule-1), PAI-1 (Plasminogen activator inhibitor-1), MCP-1 (monocyte chemoattractant protein-1) and p16 (Cyclin dependent kinase inhibitor 2A).
###end p 10
###begin title 11
Introduction
###end title 11
###begin p 12
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 428 429 428 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 474 475 474 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 526 527 526 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 544 545 544 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 828 829 828 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 830 831 830 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 0 15 <span type="species:ncbi:10633">Simian virus 40</span>
###xml 17 21 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 575 579 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 737 741 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 863 868 <span type="species:ncbi:9606">human</span>
###xml 914 919 <span type="species:ncbi:10090">mouse</span>
###xml 936 940 <span type="species:ncbi:10090">mice</span>
###xml 1199 1204 <span type="species:ncbi:10090">mouse</span>
Simian virus 40 (SV40) large T antigen (T Ag) is a multifunctional, oncoviral protein involved in numerous viral and cellular processes including viral replication, transcriptional activation and repression, blockade of differentiation, and cell transformation [1]. The ability of T Ag to transform cells depends on complex interactions between the viral oncoprotein and various intracellular proteins involved in cell control [2] and transcription regulation such as p53, [3] pRb, and the Rb-related proteins, p107 and p130 [4], and CBP/p300 [5]. The directed expression of SV40 T antigen has led to the development of several important transgenic models with spontaneous epithelial tumor formation. However, one must keep in mind that SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation [6,7]. Unlike cancer arising in the human population, tumors in genetically engineered mouse models arise in mice with well defined genetic backgrounds where genetic variability can be minimized. This offers significant advantages for studying tumor pathogenesis and molecular mechanisms of oncogenesis caused by a single initiating oncogenic event introduced through the mouse germ line.
###end p 12
###begin p 13
###xml 336 337 336 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 338 339 338 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 666 667 666 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 1174 1175 1174 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 72 77 <span type="species:ncbi:9606">human</span>
###xml 95 100 <span type="species:ncbi:10090">mouse</span>
###xml 111 116 <span type="species:ncbi:9606">human</span>
###xml 240 244 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 805 810 <span type="species:ncbi:9606">human</span>
###xml 1024 1029 <span type="species:ncbi:9606">Human</span>
###xml 1159 1165 <span type="species:ncbi:10090">murine</span>
Choroidal melanoma is the most common primary malignant ocular tumor in human adults. Relevant mouse models of human uveal melanoma still need to be developed. The majority of transgenic lines produced have been generated using the large T SV40 oncogene and either the tyrosinase promoter or the tyrosinase-related promoter-1 promoter [8,9]. Careful analysis suggests that the tumors in these models begin in the neonatal period as a peripapillary multilayered proliferation of retinal pigment epithelial cells. The early tumor cells are characterized by a spindle shape, abundant cytoplasm, round nuclei with uniform staining, and fine granules of melanin pigment [9]. Retinal, choroidal, and optic nerve invasion occurs in 6-10 weeks. By the end of this process, the cells have an appearance similar to human choroidal melanoma cells including increased basophilia, nuclear and cytoplasmic polymorphism, prominent nucleoli, abundant mitosis with tendency to metastasize, and expression of S100 calcium binding protein and Human Melanoma Black (HMB-45) antigens. Tumor growth continues with age and with retinal detachment and extrascleral extension in most murine models [9]. In some instances, the primary tumors seem to originate from the retinal pigmentary epithelium (RPE), and in other instances, they seem to originate from the RPE-choroid interface. It has also been observed in some instances that choroidal tumor formation occurs in the presence of normal RPE. Considering the neuroepithelial origin of RPE and the neural crest origin of choroidal melanocytes, this may be a non-trivial issue when studying the molecular mechanisms of tumorigenesis. The most likely explanation for the differences in transgenic expression is that the RPE is more permissive and/or sensitive to the large T antigen expression than the relatively less active uveal melanocytes.
###end p 13
###begin p 14
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 1233 1234 1233 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 1235 1237 1235 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 1238 1240 1238 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 1276 1281 1276 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tyrp1</italic>
###xml 1718 1723 1718 1723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tyrp1</italic>
###xml 1850 1855 1850 1855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tyrp1</italic>
###xml 1869 1871 1869 1871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 11 26 <span type="species:ncbi:10090">transgenic mice</span>
###xml 136 151 <span type="species:ncbi:10090">transgenic mice</span>
###xml 302 306 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 552 556 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 763 778 <span type="species:ncbi:10090">transgenic mice</span>
###xml 947 951 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1077 1081 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1609 1624 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1863 1867 <span type="species:ncbi:10090">mice</span>
###xml 1908 1913 <span type="species:ncbi:10090">mouse</span>
###xml 2034 2039 <span type="species:ncbi:9606">human</span>
We studied transgenic mice developing exclusively spontaneous malignant ocular neoplasms without any associated cutaneous melanoma. The transgenic mice that we decided to investigate (Tyrp1-TAg) resulted from the integration of multiple copies into the Y chromosome of an insert with the expression of SV40 large T antigen under the control of the tyrosine-related protein-1 promoter (Tyrp1). This model has been previously described as a model of RPE-derived tumors metastasizing to the brain, inguinal lymph nodes, and spleen [10]. Expression of the SV40 T antigen began at E10.5 and the first abnormalities in the RPE were observed at E15.5. Rapid progression was observed, leading to the development of a single malignant melanocytic tumor in each eye of the transgenic mice and invasion of the choroid. At the age of about two months, the tumor filled the entire eye, and cataracts were present in the anterior chamber. The expression of the SV40 T antigen seemed to be confined to RPE cells. However, several previous studies have shown that early oncogenic sequences of SV40 under transcriptional control of the tyrosinase promoter genetically predispose normal melanocytes to their transformation into malignant melanocytes [8,11-13]. In contrast to normal endogenous Tyrp1 mRNA levels, transgenic expression levels in neural crest-derived melanocytes is low or below the detection sensitivity threshold. This suggests the absence of important cis-acting regulatory elements favoring significant transcription of the large T antigen coding sequence located within the construct used for producing the transgenic mice that we investigated, Tyrp1-Tag. Indeed, the promoter of the tyrosinase-related family gene, Tyrp1, drives detectable transgene expression only in the RPE, even though the gene is also expressed in melanocytes as observed in Tyrp1 mutant mice [14]. Although the Tyrp1-TAg transgenic mouse model of pigmented ocular neoplasm cannot be strictly considered as a choroidal melanoma, it has many features found in human choroidal melanoma.
###end p 14
###begin p 15
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 1624 1631 1624 1631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
###xml 1637 1647 1637 1647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 1688 1693 1688 1693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ets-1</italic>
###xml 1698 1703 1698 1703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ets-2</italic>
###xml 1818 1825 1818 1825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pointed</italic>
###xml 1827 1831 1827 1831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pnt2</italic>
###xml 1834 1836 1834 1836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 1837 1839 1837 1839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 1842 1846 1842 1846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pnt2</italic>
###xml 1931 1936 1931 1936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 1941 1946 1941 1946 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 2321 2323 2321 2323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 2384 2386 2384 2386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 2735 2737 2735 2737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 2841 2843 2841 2843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 2944 2946 2944 2946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 2947 2949 2947 2949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 3117 3119 3117 3119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 3259 3261 3259 3261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 3262 3264 3262 3264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 3327 3329 3327 3329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 3625 3627 3625 3627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 3628 3630 3628 3630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 3708 3710 3708 3710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 3910 3912 3910 3912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 4033 4035 4033 4035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 4036 4038 4036 4038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 4109 4114 4109 4114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 4162 4164 4162 4164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 4165 4167 4165 4167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r37">37</xref>
###xml 4497 4499 4497 4499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r38">38</xref>
###xml 598 604 <span type="species:ncbi:9606">humans</span>
###xml 1135 1138 <span type="species:ncbi:9860">Elk</span>
###xml 1598 1603 <span type="species:ncbi:10090">mouse</span>
###xml 1605 1612 <span type="species:ncbi:9031">chicken</span>
###xml 1624 1631 <span type="species:ncbi:8355">Xenopus</span>
###xml 1637 1647 <span type="species:ncbi:7227">Drosophila</span>
###xml 1801 1811 <span type="species:ncbi:7227">Drosophila</span>
###xml 2075 2081 <span type="species:ncbi:10090">murine</span>
###xml 2171 2176 <span type="species:ncbi:10090">mouse</span>
###xml 2230 2235 <span type="species:ncbi:10090">mouse</span>
###xml 4120 4124 <span type="species:ncbi:10090">mice</span>
###xml 4624 4629 <span type="species:ncbi:10090">mouse</span>
The ETS (E26 avian leukemia oncogene) family is a diverse group of transcription factors involved in signal transduction, cell cycle progression, differentiation, angiogenesis, and invasiveness [15]. ETS proteins are mitogen-activated protein kinase (MAPK)-dependent transcription factors. They contain a conserved winged helix-turn-helix DNA-binding domain and regulate gene expression by binding to ETS-binding sequences in the promoter/enhancer regions of their target genes. These domains specifically recognize the 5'-GGAA/T-3' sequence [16]. More than 27 ETS proteins have been identified in humans [17]. The role of ETS-1 and ETS-2 has been studied for many cancers. The Ras/Raf/MERK/Erk pathway is one of several downstream signaling cascades activated by the G protein-coupled Ras proteins. Once activated, an Erk kinase at the bottom of this cascade phosphorylates cytoplasmic substrates and may be translocated to the nucleus. In the nucleus, it phosphorylates transcription factors, some of which initiate the immediate and delayed early gene responses. Erk also phosphorylates several transcription factors including ETS, Elk-1, and SAP-1. In some cancers, signaling pathways downstream from Raf may be strongly activated in the absence of direct Ras involvement. Thus, in 60%-70% of melanomas, a closely related functional analog of Raf, B-Raf, is found in a mutated constitutively activated form. It remains unclear why proliferation in these melanomas is driven by mutant B-Raf rather than mutant Ras. Highly conserved ETS protein orthologs are present in several species including mouse, chicken, nematode, Xenopus, and Drosophila. We focused our study on two ETS genes, Ets-1 and Ets-2. These genes seem to be derived from duplication of an ancestral gene that also gave rise to the Drosophila gene, pointed (Pnt2) [18,19]. Pnt2 is involved in the differentiation of photoreceptor R7. Based on this known role of ETS-1 and ETS-2 in photoreceptor differentiation and the current lack of knowledge concerning the role of these transcription factors in normal murine retina, we decided to study the production and roles of these two proteins in the normal mouse retina including RPE and in the Tyrp1-TAg transgenic mouse model of pigmented ocular neoplasm. ETS-1 and ETS-2 are produced in various tissues [20]. The role of ETS-1 in cancer has been studied extensively [21]. However, much less is known about the role of this protein in the normal and pathologic central nervous system of which both the RPE and the neural retina are major components. The production of this protein may play a major role in the pathogenesis and may be predictive of aggressive cutaneous melanoma as it is present in melanocytic lesions [22]. It is also produced in various solid tumors including epithelial tumors, sarcomas, and astrocytomas [21]. High ETS-1 levels in breast, ovary, and cervical carcinomas are associated with a poor prognosis [23,24]. ETS-1 is a prognostic marker of breast cancer, independent of other tumor markers such as nodal status, tumor size, histological grade, or estrogen receptor status [25]. The presence of ETS-1 is associated with a high incidence of lymph node metastasis in the lung, colorectal, and squamous cell carcinoma [26,27]. ETS-1 is also present in large amounts in leukemic T cells [28]. The ETS-1 transcription factor is involved in two other major carcinogenic processes, metastasis and angiogenesis. The gene encoding this factor is coexpressed with the genes encoding uPA (urokinase type plasminogen activator) and MMP-1 (matrix metalloproteinase-1) in various types of tumor [29,30]. ETS-1 is also produced together with MMP-2 and MMP-9 in pancreatic cancer [31]. The importance of ETS-1 in cancers may be partly accounted for by the role of this factor in angiogenesis. Several members of the ETS family have a combinatorial effect on vasculature development [32]. Indeed, oligonucleotides or transdominant mutant ETS-1 molecules with dominant negative effects inhibit angiogenesis [33,34], consistent with a critical role for ETS-1 in angiogenesis. However, ETS-1 null mice have no detectable vascular defects [35-37]. ETS-1 regulates several downstream effectors of angiotensin II including p21CIP, plasminogen activator inhibitor-1 (PAI-1), vascular cell adhesion molecule 1 (VCAM-1), and monocyte chemoattractant protein-1 (MCP-1) and plays a very important role in inflammation and vascular remodeling in response to angiotensine 2 (Ang II) [38] as shown by in vitro and in vivo experiments. This model makes it possible to determine whether this is also the case in a mouse model of eye cancer in which angiogenesis probably plays a major role in the development of the primary tumor and its local and distal propagation, leading to the formation of metastases.
###end p 15
###begin p 16
###xml 90 98 90 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946; APP</italic>
###xml 114 116 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r39">39</xref>
###xml 180 182 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r40">40</xref>
###xml 183 185 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r41">41</xref>
###xml 248 250 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
###xml 455 457 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r43">43</xref>
###xml 458 460 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r44">44</xref>
###xml 615 617 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r45">45</xref>
###xml 666 668 663 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r46">46</xref>
ETS-2 has mostly been studied in association with Down syndrome. ETS-2 transactivates the beta APP gene promoter [39] and the upregulation of this gene induces neuronal apoptosis [40,41]. However, ETS-2 has also been implicated in prostate cancer [42] and together with other factors including ETS-1, SRC-1 (v-src avian sarcoma [Schmidt-Ruppin A-2] viral oncogene homolog), AIB-1 (nuclear receptor coactivator 3) and NcoR (nuclear receptor co-repressor) [43,44], breast cancer. ETS-2 and ERM (ets variant 5) also significantly increase transcription of the gene encoding intercellular adhesion molecule-1 (ICAM-1) [45], which has a major role in uveal tumor growth [46]. The roles of these factors in the eye are unknown.
###end p 16
###begin p 17
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r47">47</xref>
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
###xml 142 147 <span type="species:ncbi:10090">mouse</span>
###xml 190 195 <span type="species:ncbi:9606">human</span>
###xml 310 315 <span type="species:ncbi:10090">mouse</span>
###xml 496 501 <span type="species:ncbi:10090">mouse</span>
###xml 635 640 <span type="species:ncbi:10090">mouse</span>
Here, we describe major roles for these transcription factors in a mouse model of ocular cancer. This model has been used as an ocular cancer mouse model to test new potential therapies for human choroidal melanoma [47]. Our study is the first to demonstrate the production of ETS-1 and ETS-2 in normal, whole mouse eyes during postnatal development and adulthood. Both ETS-1 and ETS-2 were detected in various ocular cell types. We also investigated the levels and roles of these factors in the mouse Tyrp-1-TAg transgenic model of ocular cancer. Levels of mRNA and protein for these two transcription factors were higher in abnormal mouse eyes during the development of tumors than in normal control eyes of the same age. We also demonstrated an upregulation of various known targets of these transcription factors that is part of a developmental pathway potentially involved in ocular cancer progression.
###end p 17
###begin title 18
Methods
###end title 18
###begin title 19
Animals
###end title 19
###begin p 20
###xml 346 348 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 306 308 <span type="species:ncbi:10090">WT</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
All animals were handled in compliance with the Association for Research in Vision and Ophthalmology (ARVO) statement for use of animals in ophthalmic and vision research. Animals were kept at 21 degreesC with a 12 h light (100 lx)/12 h dark cycle and with free access to food. We studied normal CB6 mice (WT) and transgenic CB6 Tyrp-1-TAg mice [10] between the ages of P15 and three months.
###end p 20
###begin title 21
Riboprobe synthesis
###end title 21
###begin p 22
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r48">48</xref>
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r49">49</xref>
###xml 226 231 226 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 235 240 235 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
The ETS-1 and ETS-2 riboprobes were 451 and 503 bp long, respectively, and were synthesized using a polymerase chain reaction (PCR)-based in situ hybridization technique as previously described [48,49]. PCR was performed with ETS-1 or ETS-2 gene-specific primers, incorporating a binding site for T7 RNA polymerase. Purified PCR products were then used for transcription reactions with T7 forward and reverse primers.
###end p 22
###begin title 23
In situ hybridization
###end title 23
###begin p 24
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
ETS-1 and ETS-2 riboprobes were labeled with a 10X digoxigenine (DIG) RNA labeling kit (Promega, Charbonnieres, France). In situ hybridization was performed on deparaffinized, rehydrated 5 microm eye sections from CB6 control animals. Tissue sections were incubated overnight at 65 degreesC with the probes and washed with 1X Stringent Wash Concentrate (Dako, Glostrup, Denmark) according to the manufacturer's instructions. Tissue sections were then incubated for 1 h at room temperature with anti-DIG-AP (alkaline phosphatase-conjugated antibody against DIG) and rinsed in PBS. Tissue sections were incubated with the AP substrate, nitro-blue tetrazolium/5-bromo-4-chloro-3-indolyl-phosphate (NBT/BCIP), for 30 min in the dark. Hybridized tissue sections were examined under a light microscope (LEICA, Solms, Germany). Similar amounts of probe (sense or antisense) were applied to each slide, and all slides were treated similarly in the same experiment to ensure that they could be compared. Experiments were performed in triplicate, and results were analyzed by two independent investigators.
###end p 24
###begin title 25
Peroxidase/DAB immunohistochemistry
###end title 25
###begin p 26
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 357 363 <span type="species:ncbi:9986">rabbit</span>
###xml 364 369 <span type="species:ncbi:10090">mouse</span>
Deparaffinized, rehydrated 5 microm eye and brain sections from CB6 control mice were incubated overnight at 4 degreesC with antibodies against ETS-1 (1:500; sc-350, Santa Cruz Biotechnology, Santa Cruz, CA) or ETS-2 (1:500; sc-351, Santa Cruz Biotechnology) diluted in Dako antibody diluent. Bound antibodies were detected with the ChemMate peroxidase/DAB rabbit/mouse detection kit (Dako) according to the manufacturer's instructions.
###end p 26
###begin title 27
Immunohistofluorescence
###end title 27
###begin p 28
###xml 307 311 <span type="species:ncbi:9925">goat</span>
###xml 317 323 <span type="species:ncbi:9986">rabbit</span>
Deparaffinized, rehydrated 5 microm eye sections were incubated overnight at 4 degreesC with a 1/500 dilution of antibody against ETS-1 (sc-350; Santa Cruz Biotechnology) or ETS-2 (sc-351; Santa Cruz Biotechnology) in blocking solution. Sections were washed in 1X PBS and incubated with a 1/200 dilution of goat anti-rabbit Alexa Fluor 488 antibody in a dark chamber. Tissue sections were then washed with PBS in the dark and mounted in DakoCytomation fluorescence mounting medium. Tissue sections were stored at 4 degreesC until microscopic analysis.
###end p 28
###begin title 29
Reverse-transcription polymerase chain reaction
###end title 29
###begin p 30
###xml 952 953 928 929 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
CB6 Tyrp-1 (n=5) and control mouse (n=5) eyes were removed at postnatal (P) stages P15, P20, P25, and P30 and at three months (adult). Total RNA was extracted with an extraction reagent (TRIzol; Invitrogen-Gibco, Paisley, UK) according to the manufacturer's instructions. Total RNA (1 microg) was reverse-transcribed with reverse transcriptase (SuperScript II; Invitrogen-Gibco) and oligo-dT primer according to the manufacturer's instructions. For semi-quantitative PCR, the number of cycles, amount of cDNA, and annealing temperature were optimized (data not shown). The cyclophilin gene was amplified as an internal control. PCR was then conducted in 10 microl of reaction mixture containing 0.5 microl cDNA, 1 microl 10X PCR buffer (Promega, Madison, WI), 1 microg of each specific (5'-3') and (3'-5') primers corresponding to each cDNA of interest amplified by PCR, 0.5 microg of each cyclophilin primer (5'-3' and 3'-5'), 0.2 mM dNTP, 1.5 mM MgCl2, and 0.1 U Taq DNA polymerase. An initial denaturation step at 94 degreesC for 2 min was followed by 29 cycles of heating for 1 min at 94 degreesC, 1 min at 55 degreesC, and 1 min at 72 degreesC.
###end p 30
###begin p 31
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 122 127 122 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 382 387 382 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
The ETS-2 primers (5'-CAT CCT CTG GGA ACA TCT AG-3' and 5'-TAC CCG CTG TAC ATC CAG TA-3') amplified a 451 bp product. The ETS-1 primers (5'-AAA GAG TGC TTC CTC GAG CT-3' and 5'-AGG CTG TTG AAG GAT GAC TG-3') amplified a 503 bp product. The cyclophilin primers (5'-TGG TCA ACC CCA CCG TGT TCT TCG-3' and 5'-TCC AGC ATT TGC CAT GGA CAA GA-3') amplified a 311 bp product. We also used GAPDH as a second control gene (data not shown).
###end p 31
###begin p 32
Signal was quantified with Scion image software (Frederick, MD). The experiments were performed three times. We also tested different groups of primers for each gene.
###end p 32
###begin title 33
Statistical analysis
###end title 33
###begin p 34
###xml 119 120 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
All results are expressed as the mean+/-SD. The results were compared using analysis of variance (ANOVA) and Student's t-test. A p<0.001 was considered statistically significant.
###end p 34
###begin title 35
Western blotting
###end title 35
###begin p 36
###xml 68 73 <span type="species:ncbi:10090">mouse</span>
###xml 580 586 <span type="species:ncbi:9986">rabbit</span>
###xml 704 708 <span type="species:ncbi:9925">goat</span>
###xml 813 824 <span type="species:ncbi:3704">horseradish</span>
###xml 848 854 <span type="species:ncbi:9986">rabbit</span>
###xml 863 867 <span type="species:ncbi:9925">goat</span>
Total proteins were extracted from CB6 control (n=5) and CB6 Tyrp-1 mouse (n=5) eyes at P15, P20, P25, P30, and three months of age using an extraction reagent (TRIzol; Invitrogen-Gibco) according to the manufacturer's instructions. Proteins (50 mug; Bradford protein assay) were separated by electrophoresis (SDS-PAGE in a 10% polyacrylamide gel). Separated proteins were transferred onto a nitrocellulose membrane (Trans-Blot Transfer Medium; Bio-Rad, Hercules, CA), which was then blocked by incubation for 1 h with 5% nonfat milk. Membranes were then incubated overnight with rabbit anti-ETS-1 antibody (sc-350; Santa Cruz Biotechnology), anti-ETS-2 antibody (sc-351; Santa Cruz Biotechnology), or a goat anti-beta-actin antibody (Santa Cruz Biotechnology). They were then washed and incubated for 1 h with a horseradish peroxidase-linked anti-rabbit or anti-goat secondary antibody (Santa Cruz). Proteins were detected by enhanced chemiluminescence (ECL; PerkinElmer Life and Analytical Sciences Inc, Courtaboeuf, France). The experiments were performed three times.
###end p 36
###begin title 37
Results
###end title 37
###begin title 38
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS</italic>
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
ETS mRNA and protein localization in adult mouse eyes
###end title 38
###begin p 39
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ets-1</italic>
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ets-2</italic>
###xml 129 136 129 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pointed</italic>
###xml 138 142 138 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pnt2</italic>
###xml 392 397 392 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 402 407 402 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 496 501 496 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 506 511 506 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 532 543 532 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A,E</xref>
###xml 830 841 830 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A,E</xref>
###xml 866 871 866 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 953 958 953 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 112 122 <span type="species:ncbi:7227">Drosophila</span>
###xml 452 457 <span type="species:ncbi:10090">mouse</span>
The genes, Ets-1 and Ets-2, seem to be derived from duplication of an ancestral gene that also gave rise to the Drosophila gene, pointed (Pnt2). This gene is involved in the differentiation of the photoreceptor, R7, suggesting that ETS-1 and ETS-2 may be involved in the development and/or biological functions of the neural retina. We used in situ hybridization to study the distribution of ETS-1 and ETS-2 mRNA in paraffin-embedded sections of adult mouse eye tissue. We detected mRNA for both ETS-1 and ETS-2 in the neuroretina (Figure 1A,E). We found mRNA for these factors in the ganglion cell layer (GC), inner nuclear layer (INL), outer nuclear layer (ONL), and photoreceptor inner segments (PIS) but not in the photoreceptor outer segments. Both transcripts were also present in the adult retinal pigment epithelium (RPE; Figure 1A,E) and uveal melanocytes. ETS-1 mRNA was not produced in detectable amounts in the outer plexiform layer whereas ETS-2 mRNA was clearly produced in significant amounts in this layer, which consists primarily of fibers and synapses. This observation was validated in several sets of repeated experiments.
###end p 39
###begin p 40
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 79 84 79 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 89 94 89 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 213 214 213 214 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 219 220 219 220 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 407 408 407 408 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 413 414 413 414 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 474 475 474 475 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 488 489 488 489 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 611 612 611 612 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 617 618 617 618 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 668 673 668 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 675 676 675 676 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 681 686 681 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 688 689 688 689 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 822 823 822 823 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 836 837 836 837 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
###xml 124 129 <span type="species:ncbi:10090">mouse</span>
###xml 322 327 <span type="species:ncbi:10090">mouse</span>
###xml 650 655 <span type="species:ncbi:10090">mouse</span>
###xml 732 737 <span type="species:ncbi:10090">mouse</span>
###xml 899 904 <span type="species:ncbi:10090">mouse</span>
Distribution of ETS-1 and ETS-2 mRNAs and proteins in the adult mouse eye. The ETS-1 and ETS-2 mRNAs were detected in adult mouse tissue sections by in situ hybridization (HIS), and their distributions are shown (A and E, respectively). The ETS-1 and ETS-2 proteins were detected by immunohistofluorescence (IHC) in adult mouse tissue sections. The specific immunostaining patterns obtained are also shown (B and F, respectively). The retinal tissue distributions of ETS-1 (B) and ETS-2 (F) proteins appeared to be somewhat different whereas the distribution of the transcripts corresponding to these proteins (A and E) seemed to be similar in adult mouse retina. The ETS-1 (C)and ETS-2 (G) mRNAs show the negative control in adult mouse tissue sections by in situ hybridization obtained with sense riboprobes. The ETS-1 (D) and ETS-2 (H) immunohistofluorescence shows the negative control in adult mouse tissue section. The results were obtained with the second antibody alone. The nucleus was counterstained with DAPI. The scale bar represents 100 microm. GCL: ganglion cell layer; IPL: inner plexiform layer; INL: inner nuclear layer; OPL: outer plexiform layer; ONL: outer nuclear layer, RPE: retinal pigment epithelium; PIS: photoreceptor inner segment.
###end p 40
###begin p 41
###xml 178 189 178 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1B,F</xref>
###xml 194 202 194 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 237 246 237 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1C</xref>
###xml 259 268 259 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1G</xref>
###xml 328 337 328 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1D</xref>
###xml 350 359 350 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1H</xref>
###xml 402 410 402 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 498 503 498 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 517 526 517 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1B</xref>
###xml 1359 1368 1359 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1F</xref>
###xml 1574 1585 1574 1585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2A,C</xref>
###xml 1787 1796 1787 1796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1D</xref>
###xml 2043 2056 2043 2056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2B,D,F</xref>
###xml 164 169 <span type="species:ncbi:10090">mouse</span>
###xml 1218 1222 <span type="species:ncbi:10090">mice</span>
###xml 1714 1719 <span type="species:ncbi:10090">mouse</span>
We also performed immunohistofluorescence and immunohistochemistry analyses to determine the cellular distribution of ETS-1 and ETS-2 immunoreactivity in the adult mouse retina (Figure 1B,F and Figure 2). The negative controls of ETS-1 (Figure 1C) and ETS-2 (Figure 1G) in situ hybridization and the negative controls of ETS-1 (Figure 1D) and ETS-2 (Figure 1H) immunohistofluorescence are presented in Figure 1. The retinal pattern of immunoreactivity for ETS-1 matched the retinal distribution of ETS-1 transcripts (Figure 1B). We detected ETS-1 immunoreactivity in the nerve fiber layer (NFL), the ganglion cell layer (GCL), the INL (with apparent stronger labeling of the bipolar neuron cell bodies on either side of the INL and significant labeling probably of the cell bodies of amacrine cells). Horizontal cell bodies were detected at the interface of the ONL and INL on the basis of morphological criteria. However, double-labeling experiments are required to confirm unambiguously the nature of the cell bodies immunolabeled for ETS-1 in the INL and in the region close to the ONL. No significant ETS-1 immunostaining was observed in the IPL whereas ETS-2 immunostaining was strong in this cell layer in adult mice. ETS-1 immunoreactivity in the OPL was detectable but much weaker than ETS-2 immunoreactivity in the same layer, which was very strong (Figure 1F). ETS-1 immunolabeling in the ONL was weaker than that in the INL, but both the nuclei and cytoplasm of the ONL cells appeared to be stained. The RPE displayed strong levels of immunoreactivity for ETS-1 (Figure 2A,C), and significant ETS-1 immunostaining was also detected in uveal melanocytes. ETS-2 immunoreactivity was detected in the adult mouse retina, but its cellular distribution differed from that of ETS-1 (Figure 1D). The ETS-2 antibody used seemed to almost exclusively stain the cytoplasm surrounding the nuclei of cells in the GCL, ONL, INL, and RPE cell layer. We also detected distinct ETS-2 immunostaining in the nerve cell layer, GCL, IPL, and PIS layer (Figure 2B,D,F). We found positive immunolabeling for ETS-2 in the nucleus and cytoplasm of some cells in the INL, but most cell bodies of the INL displayed essentially cytosolic ETS-2 immunostaining mostly at the periphery of the labeled cells. In some cases, the staining surrounded the nuclei and appeared to be very close to, if not associated with, the cytoplasmic membranes. Examination of eye tissue sections under a fluorescence microscope at low and medium magnification did not reveal significant immunoreactivity signals for ETS-2 in the ONL. However, at high magnification, the nuclei of ONL cells resembled ghost nuclei surrounded by the weakly labeled ETS-2-immunoreactive cytosol. Immunoperoxidase labeling for ETS-2 was positive in all the cell bodies located in the GCL, INL, ONL, and RPE cell layer, demonstrating greater homogeneity. With this technique, only the cytosol appeared to be significantly labeled, although much less strongly compared to ETS-1 immunostaining. Significant ETS-2 immunostaining of the OPL was clearly visible. The ETS-2 immunoreactivity in the RPE and uveal melanocytes was significant but much weaker than ETS-1 immunoreactivity in the same cell types. We cannot exclude the possibility that Muller cells were also immunostained for ETS-2 whereas this seems less likely for ETS-1. No difference in the respective patterns of ETS-1 and ETS-2 immunostaining was detected during postnatal ocular development between P15 and adulthood. The most striking differences between the retinal immunostaining patterns for ETS-1 and ETS-2 were the stronger immunolabeling of the IPL and OPL for ETS-2 than for ETS-1 and the much lower immunoreactivity of the ONL for ETS-2 than for ETS-1.
###end p 41
###begin p 42
###xml 194 195 194 195 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 196 198 196 198 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D)</bold>
###xml 207 208 207 208 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 213 214 213 214 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 464 465 464 465 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 470 471 470 471 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1167 1168 1167 1168 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1181 1182 1181 1182 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 1293 1294 1293 1294 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 1307 1308 1307 1308 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 1615 1616 1615 1616 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</bold>
###xml 1628 1629 1628 1629 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</bold>
###xml 1712 1713 1712 1713 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">J</bold>
###xml 1725 1726 1725 1726 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</bold>
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
Distribution of ETS transcription factor proteins in mouse adult retina, cornea, and ciliary body as determined by immunohistofluorescence. Immunohistofluorescence for ETS-1 and ETS-2 is shown (A-D). ETS-1 (A and C) is present in the ganglion cell layer (GCL) and inner nuclear layer (INL) with intense homogeneous staining in the outer nuclear layer (ONL). It is also detected in the photoreceptor inner segment (PIS) and retinal pigment epithelium (RPE). ETS-2 (B and D) is also present in significant amounts in the GCL. Weak ETS-2 immunoreactivity is observed in the INL and ONL. In these layers, at higher magnification, very few cell bodies are immunostained. The immunolabeling detected seems to be restricted to the nuclear membranes whereas the nucleoplasm seems to be devoid of ETS-2 immunolabeling. In contrast to what was observed for the retinal distribution of ETS-1 immunoreactivity, strong ETS-2 immunolabeling is observed in the inner plexiform layer (IPL) and outer plexiform layer (OPL). As observed for ETS-1, the PIS and RPE display marked ETS-2 immunostaining, although the RPE seems to be less strongly stained for ETS-2 than for ETS-1. ETS-1 (E) and ETS-2 (F) protein distributions are shown in the adult retina with the DAB immunostaining protocol. We observed ETS-1 (G) and ETS-2 (H) immunolabeling in the adult ciliary body. In the ciliary body, ETS-1 and ETS-2 proteins are detected in the nonpigmented ciliary epithelial cells (NPCE). No significant labeling is observed in the pigmented ciliary epithelial cells (PCE). ETS-1 immunolocalisation was detected in the adult cornea at low (I) and high (K) magnification. ETS-2 immunolocalisation was detected in the adult cornea at low (J) and high (L) magnification. In the cornea, ETS-1 and ETS-2 immunoreactivities are observed in the epithelium (CEp), the stroma (CS), the stromal keratocytes (ke, arrows), and the endothelium (CEn).
###end p 42
###begin p 43
###xml 91 99 91 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 69 74 <span type="species:ncbi:10090">mouse</span>
###xml 200 205 <span type="species:ncbi:10090">mouse</span>
We also detected immunoreactivity for ETS-1 and ETS-2 in other adult mouse eye structures (Figure 2) such as the ciliary bodies, corneal epithelium, keratocytes, and corneal endothelial cells. In the mouse adult retina, ETS-1 is mostly present in the nuclei while ETS-2 is mostly present in the cytosol with smaller amounts present in the nuclei. ETS-2 was present in large amounts in dendritic, synaptic, and axonal retinal areas. The possibility of a structural role for ETS-2 in addition to its role as a transcription factor cannot be ruled out for retinal neurons. These findings suggest that ETS-1 and ETS-2 have overlapping but distinct roles in the biological functions of the eye.
###end p 43
###begin title 44
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 37 43 <span type="species:ncbi:10090">murine</span>
ETS-1 and ETS-2 are upregulated in a murine model of ocular cancer
###end title 44
###begin p 45
###xml 143 148 143 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 153 158 153 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 298 303 298 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 308 313 308 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 341 346 341 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 351 356 351 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 417 428 417 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3A,C</xref>
###xml 435 440 435 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 561 570 561 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3A</xref>
###xml 573 578 573 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 673 678 673 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 761 766 761 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 863 872 863 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3C</xref>
###xml 170 172 <span type="species:ncbi:10090">WT</span>
###xml 186 191 <span type="species:ncbi:10090">mouse</span>
###xml 536 540 <span type="species:ncbi:10090">mice</span>
###xml 552 554 <span type="species:ncbi:10090">WT</span>
###xml 555 559 <span type="species:ncbi:10090">mice</span>
###xml 659 663 <span type="species:ncbi:10090">mice</span>
###xml 821 823 <span type="species:ncbi:10090">WT</span>
###xml 824 829 <span type="species:ncbi:10090">mouse</span>
We investigated the roles of ETS-1 and ETS-2 in the development of pigment neoplasms using semi-quantitative RT-PCR to compare mRNA levels for ETS-1 and ETS-2 in normal (WT) and tumoral mouse model (TYRP-1-TAg) whole eyes. Cytophilin was used as an internal standard for relative quantification of ETS-1 and ETS-2 mRNA levels. We determined ETS-1 and ETS-2 mRNA levels at P15, P20, P25, P30, and three months of age (Figure 3A,C). The ETS-1/cyclophilin mRNA ratio in whole eyes almost doubled between P25 and three months in TYRP-1-TAg mice but not in WT mice (Figure 3A). ETS-2 mRNA levels were significantly higher in the TYRP-1-TAg model than in wild-type mice. At P25, ETS-2 mRNA levels were more than four times higher in TYRP-1-TAg than in the wild-type. ETS-2 mRNA levels were slightly lower in TYRP-1-TAg than in WT mouse eyes at P30 and at three months (Figure 3C).
###end p 45
###begin p 46
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 374 375 374 375 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 380 381 380 381 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 450 451 450 451 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 464 465 464 465 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 588 589 588 589 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 602 603 602 603 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 804 805 804 805 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 810 811 810 811 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 912 913 909 910 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 918 919 915 916 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 58 63 <span type="species:ncbi:10090">mouse</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 129 131 <span type="species:ncbi:10090">WT</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
Overproduction of ETS-1 and ETS-2 mRNAs and proteins in a mouse model of ocular neoplasm (Tyrp-1), with respect to control mice (WT) between P15 and three months. mRNA levels were determined by semi-quantitative RT-PCR. The values shown correspond to the levels of overproduction of ETS-1 and ETS-2 with respect to levels in normal control mice at the same age. The graphs (A and C) show the intensity level of each PCR band, corresponding to ETS-1 (A) and ETS-2 (C) as measured by densitometric analysis. The cyclophilin is used as an internal standard control. The PCR bands for ETS-1 (B) and ETS-2 (D) are shown. The relative levels are calculated as the ratio of intensities of each ETS band to the cyclophilin band for each lane. Error bars indicate SEM. Proteins were detected by western blotting (E and F). Levels were quantified using Scion image and normalized using beta-actin as an internal standard (G and H).
###end p 46
###begin p 47
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 67 72 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 224 235 224 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3E-H</xref>
###xml 215 217 <span type="species:ncbi:10090">WT</span>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
###xml 417 419 <span type="species:ncbi:10090">WT</span>
###xml 572 576 <span type="species:ncbi:10090">mice</span>
###xml 976 991 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1081 1096 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1121 1125 <span type="species:ncbi:10090">mice</span>
We investigated the consequences of this upregulation of ETS-1 and ETS-2 mRNA levels by western blotting to compare protein levels. We studied ETS-1 and ETS-2 protein levels at the same time points in Tyrp1-TAg and WT mice (Figure 3E-H). ETS-1 and ETS-2 protein levels were significantly higher in Tyrp1-TAg than in wild-type mice for all time points between P25 and three months. ETS-1 protein was first detected in WT eyes at P25 by western blotting. The exposure time allowing the readily detection of ETS-1 and ETS-2 by western blotting in the retina of wild-type CB6 mice gave highly saturated signals for ETS-1 protein extracted from eyes affected by ocular tumor. However, the levels of ETS-2 protein in eyes with ocular tumor could still be quantified and interpreted using this exposure time. The ETS-1 signal was not detected on western blots of normal eyes using shorter exposure times but was readily detected and quantified on western blots of ocular tumors from transgenic mice. These results show a marked increase in protein levels for ETS-1 and ETS-2 after P25 in transgenic mice compared to the control mice.
###end p 47
###begin p 48
Our findings suggest that the genes encoding ETS-1 and/or ETS-2 may play a role in the emergence and/or progression of ocular tumor.
###end p 48
###begin title 49
Expression of ETS-1 and ETS-2 in the mass of tumor cells
###end title 49
###begin p 50
###xml 353 361 353 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4</xref>
###xml 332 338 <span type="species:ncbi:10090">murine</span>
###xml 473 477 <span type="species:ncbi:10090">mice</span>
We previously observed ETS-1 and ETS-2 overproduction. However, the results obtained did not determine whether ETS-1 or ETS-2 was increased exclusively in the retina and/or RPE per se and in the ocular tumor only or throughout the whole eye. We addressed this issue using immunohistofluorescence to detect these two proteins in the murine ocular tumor (Figure 4). At P15 and P20, the amounts and distribution of these proteins were similar between Tyrp-1 TAg and wild-type mice.
###end p 50
###begin p 51
###xml 262 263 258 259 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 307 308 303 304 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 476 477 472 473 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 538 539 534 535 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 773 774 765 766 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 794 795 786 787 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 931 932 923 924 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 952 953 944 945 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 157 162 <span type="species:ncbi:10090">mouse</span>
###xml 235 240 <span type="species:ncbi:10090">mouse</span>
###xml 301 305 <span type="species:ncbi:10090">mice</span>
###xml 454 469 <span type="species:ncbi:10090">transgenic mice</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
###xml 788 792 <span type="species:ncbi:10090">mice</span>
###xml 946 950 <span type="species:ncbi:10090">mice</span>
ETS-1 and ETS-2 distribution in the tumor. We detected ETS-1 protein in the tumor by immunohistofluorescence on 5 microm paraffin-embedded sections of whole mouse eyes. Distributions of ETS-1 in the posterior pole of Tyrp-1 transgenic mouse eye tissue sections (A) and in tissue sections from control mice (B) are shown at P25; ETS-1 is significantly expressed in the mass of tumor cells. At three months, the melanoma tumor reaches the cornea of Tyrp-1 transgenic mice eyes (C) whereas in control mice, only lens fibers can be observed (D). ETS-1 levels are expressed within the mass of tumor cells (MTC). We detected ETS-2 protein by immunofluorescence on 5 microm paraffin embedded tissue sections. Distributions of ETS-2 protein at P25 in the posterior pole of Tyrp-1 (E) and control mice (F) are also shown; ETS-2 is significantly expressed in the mass of tumor cells. Distribution of ETS-2 protein at three months in Tyrp-1 (G) and control mice (H). ETS-2 is present within all cells contained within the mass of tumor cells (MTC). The nucleus was counterstained with DAPI. The scale bar represents 100 microm.
###end p 51
###begin p 52
###xml 145 154 145 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4A</xref>
###xml 243 252 243 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4B</xref>
###xml 640 649 640 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4C</xref>
###xml 847 858 847 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4E,F</xref>
###xml 996 1007 996 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4G,H</xref>
###xml 226 241 <span type="species:ncbi:10090">transgenic mice</span>
###xml 804 819 <span type="species:ncbi:10090">transgenic mice</span>
###xml 837 839 <span type="species:ncbi:10090">WT</span>
###xml 841 845 <span type="species:ncbi:10090">mice</span>
###xml 987 989 <span type="species:ncbi:10090">WT</span>
###xml 990 994 <span type="species:ncbi:10090">mice</span>
We observed specific cellular immunostaining for ETS-1 in the retinal site surrounding the optic nerve at the point of tumor development at P25 (Figure 4A). The neuroretina was completely disorganized at the posterior pole of transgenic mice (Figure 4B) with a mass of cells producing ETS-1. This mass of tumor cells (MTC) forms a "collar button" or "mushroom"-like structure, which is highly characteristic of choroidal melanoma. At three months, this disorganization was more extensive, spreading from the posterior pole to the anterior. We observed a structure corresponding to a thickening of the pigmentary epithelium producing ETS-1 (Figure 4C) both in malignant RPE cells and in malignant melanocytes. Like ETS-1, ETS-2 was produced in the MTC at the posterior pole at P25 at higher levels in the transgenic mice than in control (WT) mice (Figure 4E,F). At three months, we also observed a thickening of the pigmentary epithelium, producing ETS-2 protein at higher levels than in WT mice (Figure 4G,H).
###end p 52
###begin title 53
Overexpression of ETS-1 and ETS-2 target genes in ocular cancer
###end title 53
###begin p 54
###xml 353 358 353 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r50">50</xref>
###xml 452 460 452 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16INK4A</italic>
###xml 567 572 567 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PAI-1</italic>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r51">51</xref>
###xml 727 733 727 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ICAM-1</italic>
###xml 803 805 803 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r45">45</xref>
We previously showed that the transcription factors, ETS-1 and ETS-2, were both upregulated from P20 to three months in our ocular cancer model. We therefore assessed whether this overproduction of ETS-1 was correlated with an upregulation of some of its known target genes in our model of ocular cancer. Three genes are known to be regulated by ETS-1, MCP-1 (monocyte chemoattractant protein-1), which has growth promoting effects (reviewed in [50]); p16INK4A cyclin-dependent kinase, which is directly activated by ETS-1 and involved in replicative senescence; and PAI-1 (plasminogen activator inhibitor type-1), which is considered a major regulator of tumor invasion and metastasis and of cancer-related angiogenesis [51]. ICAM-1, which is involved in angiogenesis, is directly controlled by ETS-2 [45].
###end p 54
###begin p 55
###xml 368 376 368 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f5">Figure 5</xref>
###xml 421 426 421 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 427 432 427 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 88 90 <span type="species:ncbi:10090">WT</span>
###xml 96 111 <span type="species:ncbi:10090">transgenic mice</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
###xml 337 341 <span type="species:ncbi:10090">mice</span>
###xml 475 479 <span type="species:ncbi:10090">mice</span>
###xml 982 987 <span type="species:ncbi:10090">mouse</span>
We performed semi-quantitative RT-PCR assays on total RNA from the eyes of normal mice (WT) and transgenic mice (Tyrp-1-TAg). We quantified mRNA levels for these target genes using the endogenous cyclophilin gene for normalization. Levels of mRNA were significantly higher for all these target genes in Tyrp-1-TAg mice than in wild-type mice from P20 to three months (Figure 5). This result is consistent with the higher ETS-1/ETS-2 mRNA and protein levels observed in these mice. Our data suggest that ETS-1 and ETS-2 are involved in one or more signaling pathways activating the expression of a set of genes involved in ocular tumor progression and the probable acquisition of high metastatic potential by this tumor. These findings demonstrate the relevance of one or more signaling pathways, that are downstream ETS-1 and ETS-2, and the relevance of crucial molecular building blocks of one or more of these pathways, in the ocular tumor development occurring in the transgenic mouse model studied.
###end p 55
###begin p 56
###xml 61 67 61 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ICAM-1</italic>
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP-1</italic>
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PAI-1</italic>
###xml 87 90 87 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 277 278 277 278 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 360 361 360 361 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 442 443 442 443 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 524 525 524 525 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 252 256 <span type="species:ncbi:10090">mice</span>
Expression of several known target genes of ETS-1 and ETS-2. ICAM-1, MCP-1, PAI-1, and p16 mRNA levels were evaluated by semi-quantitative RT-PCR and normalized using cyclophilin mRNA as a control. These mRNA levels were compared with those in control mice of the same age. In A, we observed that ICAM-1 is upregulated in Tyrp-1 model from p20 to 3 months. In B, we observed that MCP-1 is upregulated in Tyrp-1 model from p25 to 3 months. In C, we observed that PAI-1 is upregulated in Tyrp-1 model from p20 to 3 months. In D, we observed that p16 is upregulated in Tyrp-1 model from p25 to 3 months.
###end p 56
###begin title 57
Discussion
###end title 57
###begin p 58
###xml 155 160 155 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 165 170 165 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r52">52</xref>
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r53">53</xref>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r54">54</xref>
###xml 354 365 354 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila,</italic>
###xml 365 369 365 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pnt2</italic>
###xml 387 392 387 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 397 402 397 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r55">55</xref>
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r57">57</xref>
###xml 2225 2227 2225 2227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r58">58</xref>
###xml 2796 2798 2796 2798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r59">59</xref>
###xml 190 195 <span type="species:ncbi:10090">mouse</span>
###xml 336 341 <span type="species:ncbi:9606">human</span>
###xml 354 364 <span type="species:ncbi:7227">Drosophila</span>
###xml 521 526 <span type="species:ncbi:10090">mouse</span>
###xml 624 629 <span type="species:ncbi:10090">mouse</span>
###xml 2327 2334 <span type="species:ncbi:9031">chicken</span>
###xml 2467 2472 <span type="species:ncbi:9606">human</span>
We describe here the expression profiles for ETS-1 and ETS-2, two members of the ETS family of transcription factors. We first investigated the pattern of ETS-1 and ETS-2 gene expression in mouse eyes. Previous studies have reported the detection of ETS transcription factors including PEA3 [52], ELF3 [53] and ESE-1 [54] in rodent and human retinas. In Drosophila,Pnt2, the ortholog of ETS-1 and ETS-2, is involved in eye development [55-57]. Our study is the first to demonstrate the presence of ETS-1 and ETS-2 in the mouse eye and to show that these two transcription factors have different spatial distributions in the mouse neuroretina. We detected ETS-1 immunoreactivity in the ganglion cell layer, the inner and outer nuclear layers, and the photoreceptors inner segments. No significant ETS-1 immunoreactivity could be detected in any of the plexiform layers. We also detected ETS-1 immunostaining in the RPE. ETS-2 immunoreactivity was detected in the GCL, the INL, the PIS, and the RPE, but no significant ETS-2 immunolabeling could be detected in the ONL. This absence of ETS-2 immunostaining in the ONL suggests that ETS-2 is not directly involved in specific photoreceptor functions. Although no ETS-2 immunostaining could be detected in the ONL, significant ETS-2 immunoreactivity could be observed in the OPL. These findings suggest that ETS-2 might be involved in synaptic transmission. Further studies are required to define the role of ETS-1 and ETS-2 in the different retinal layers. A major finding of our study is the striking difference observed between the cellular immunostaining pattern observed for ETS-1 and that observed for ETS-2. While ETS-1 appeared to be localized mostly in retinal cell nuclei, ETS-2 seemed to be mostly in the cytosol of retinal cells. Electron microscopy and live imaging experiments are required to unambiguously confirm these observations. Our observations in the retina are consistent with those previously reported for other parts of the central nervous system (CNS; data not shown). The differences in tissue and intracellular ETS-1 and ETS-2 retinal immunostaining patterns suggest that ETS-1 and ETS-2 might have different biological functions in the adult retina [58]. This contrasts with previous general studies of the distribution of ETS-1 and ETS-2. Indeed, the chicken ETS protein, which contains both the ETS-1 and ETS-2 domains, is uniformly distributed between the cytoplasm and nucleus whereas in human and other mammalian tissues producing these transcription factors, ETS-1 localization is generally cytoplasmic and ETS-2 localization is nuclear. Differences in immunostaining patterns for these two proteins in neural tissues are consistent with the notion of different biological functions for ETS-1 and ETS-2 in the CNS [59].
###end p 58
###begin p 59
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 116 121 116 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 126 131 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r60">60</xref>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r61">61</xref>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r62">62</xref>
###xml 767 771 767 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPB</italic>
###xml 828 833 828 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tymps</italic>
###xml 835 844 835 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pol-&#945;</italic>
###xml 850 854 846 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Skp2</italic>
###xml 1429 1431 1425 1427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r63">63</xref>
###xml 1432 1434 1428 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r64">64</xref>
###xml 1655 1656 1651 1652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 1789 1791 1785 1787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r65">65</xref>
###xml 1814 1819 1810 1815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 1824 1829 1820 1825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 2176 2180 2172 2176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DNMT</italic>
###xml 2183 2185 2179 2181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r66">66</xref>
###xml 2186 2188 2182 2184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r69">69</xref>
###xml 2218 2221 2214 2217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HAT</italic>
###xml 2246 2250 2242 2246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HDAC</italic>
###xml 2421 2423 2417 2419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r70">70</xref>
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 672 676 <span type="species:ncbi:10090">mice</span>
###xml 758 762 <span type="species:ncbi:10090">mice</span>
###xml 989 994 <span type="species:ncbi:10090">mouse</span>
###xml 1140 1144 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1641 1646 <span type="species:ncbi:10090">mouse</span>
###xml 1717 1721 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
We then investigated ETS-1 and ETS-2 gene expressions in a mouse model of pigmented ocular neoplasm. We showed that ETS-1 and ETS-2 mRNA and protein levels were higher in these mice than in wild-type mice. This is consistent with previous studies [17,60,61] that demonstrated the fact both ETS-1 and ETS-2 may play important roles in the development of ocular cancer. We also investigated the possible role of another member of the ETS family in the development of this tumor. GA BINDING PROTEIN (GABP) is an ETS transcription factor required for normal cell cycle progression [62]. We used semi-quantitative RT-PCR to assess differences in GABP levels between Tyrp-1-TAg mice and controls. No significant difference was found between transgenic and control mice for GAPB mRNA levels or in the mRNA levels of GABP target genes, Tymps, Pol-alpha, and Skp2 (data not shown). We have so far not found any evidence suggesting that the increased expression of ETS-1 and ETS-2 observed in these mouse ocular neoplasms resulted from the inactivation of p53 or Rb. The importance of the large T antigen interaction with Rb proteins and with p53 in SV40 transformation is well established. However, is this the whole story or do other T antigen activities contribute to the tumorigenic phenotype? Indeed, genetic studies suggest that the inactivation of pRb and p53 may not account for the full transformation potential of the T antigen [63,64]. Indeed, several cellular T antigen binding proteins have been identified that, based on their known functions, have potential to contribute to transformation and possibly progression of T antigen induced mouse tumors [6]. The involvement of chromatin and histone deacetylation in SV40 T antigen transcription regulation has been recently demonstrated [65]. Its consequences on ETS-1 and ETS-2 gene expression remain to be investigated. During malignant transformation, cancer cells acquire genetic mutations that override the normal mechanisms controlling cellular proliferation. Importantly, malignant progression has been shown to be triggered and/or accelerated by epigenetic mutations caused by alterations of DNA Methyltransferase-1 (DNMT) [66-69], histone acetyltransferase (HAT), Histone deacetylases (HDACs) genes, and other mutator or modifier genes. Histone tail modifications along with DNA methylation are the most studied epigenetic events related to cancer progression [70]. Another area, which still remains to a large extent a terra incognita, is related to the transcription factors controlling ETS-1 and ETS-2 expression, although several ETS transcription factors have been shown to be downstream effectors of the Ras/Raf/MERK/Erk pathway. Our study demonstrates that ETS-1 and ETS-2 play a specific role in the development of T antigen induced RPE tumors.
###end p 59
###begin p 60
###xml 14 16 14 16 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 909 914 909 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 919 924 919 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 1096 1098 1096 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r71">71</xref>
###xml 1141 1146 1141 1146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 1628 1630 1628 1630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r72">72</xref>
###xml 1631 1633 1631 1633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r73">73</xref>
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
###xml 77 81 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 137 142 <span type="species:ncbi:10090">mouse</span>
###xml 180 185 <span type="species:ncbi:9606">human</span>
###xml 279 284 <span type="species:ncbi:9606">human</span>
###xml 583 588 <span type="species:ncbi:9606">human</span>
###xml 726 731 <span type="species:ncbi:9606">human</span>
###xml 825 830 <span type="species:ncbi:9606">human</span>
###xml 1162 1167 <span type="species:ncbi:9606">human</span>
###xml 1376 1381 <span type="species:ncbi:10090">mouse</span>
###xml 1413 1418 <span type="species:ncbi:9606">human</span>
###xml 1512 1517 <span type="species:ncbi:10090">mouse</span>
Penna et al. [10] previously developed a transgenic mouse model in which the SV40 T antigen induces RPE tumor formation. This transgenic mouse model recapitulates many features of human choroidal melanoma. Indeed, the tumoral cells in this model develop an appearance similar to human choroidal melanoma cells including increased basophilia, nuclear and cytoplasmic polymorphism, prominent nucleoli, abundant mitosis with a tendency to metastasize, and expression of S100 and HMB-45 antigens. Furthermore, metastases in this model mostly develop in the liver, the major location for human choroidal melanoma metastasis. In the model we investigated, the major site of metastasis is the brain. It should be stressed that 5% of human choroidal melanomas have metastasis in the brain and not in the liver, particularly when the human choroidal melanoma occurs close to the optic disk. Therefore, upregulation of ETS-1 and ETS-2 could also occur in choroidal melanoma. This hypothesis has been confirmed by recent findings. Indeed, microarray gene expression profiling analysis by Harbour and Onken [71] (and personal communication) showed that ETS-2 mRNA levels in human choroidal melanoma were four times higher than those in adult normal melanocytes. These findings are consistent with those of our study, indicating that ETS-2 is indeed increased in the Tyrp-1 TAg transgenic mouse ocular pigmented neoplasms and human choroidal melanoma. The results obtained highlight the clinical relevance of this transgenic mouse model for testing new drugs to potentially overcome the high level of chemical resistance of uveal melanomas [72,73].
###end p 60
###begin p 61
###xml 263 268 263 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 298 303 298 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 786 788 786 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r74">74</xref>
###xml 789 791 789 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r75">75</xref>
###xml 956 961 956 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 966 971 966 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 1271 1276 1271 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 1281 1286 1281 1286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 1525 1527 1517 1519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r76">76</xref>
###xml 1528 1530 1520 1522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r79">79</xref>
###xml 1582 1584 1574 1576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r80">80</xref>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 214 218 <span type="species:ncbi:10090">mice</span>
###xml 224 226 <span type="species:ncbi:10090">WT</span>
Both ETS-1 and ETS-2 were produced at higher levels in Tyrp-1 TAg mice than in controls. Interestingly, in triplicate experiments using semi-quantitative PCR and western blotting to compare ocular tumors in Tyrp-1 mice with WT eyes at the same age, we found that ETS-2 mRNA levels were higher than ETS-1 mRNA levels, but ETS-1 protein levels were higher than ETS-2 protein levels. These results may be accounted for by different posttranscriptional regulatory mechanisms. Primary tumors and their various developmental stages can now be characterized molecularly by comparative whole genome expression profiling, the use of chips for mRNA detection, and proteomic techniques. MicroRNA expression in tumors was recently shown to provide valid specific signatures for each type of tumor [74,75]. The study of other types of regulatory RNAs might increase the accuracy of molecular characterization for each tumor. Different posttranscriptional regulation of ETS-1 and ETS-2 mRNAs by specific microRNAs and/or RNA-binding proteins could potentially explain our findings. Our observations could also be explained by epigenetic changes in tumor cells having differential effects on the regulation of genes encoding transcription factors and/or cotranscriptional regulators of ETS-1 and ETS-2. Further experiments are required to test these hypotheses. For example, the role of Protein Kinase Calpha (PKCalpha) should be explored because it is implicated in cell proliferation, cell migration, and tumor cell invasion in melanoma [76-79] and increases the stability of the ETS-1 protein [80].
###end p 61
###begin p 62
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r81">81</xref>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r82">82</xref>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r83">83</xref>
###xml 813 818 813 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 823 828 823 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
###xml 1141 1143 1141 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 1170 1173 1170 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS</italic>
###xml 1577 1579 1577 1579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r84">84</xref>
###xml 1611 1613 1611 1613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r85">85</xref>
###xml 1632 1634 1632 1634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r86">86</xref>
###xml 1635 1637 1635 1637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r87">87</xref>
###xml 1660 1662 1660 1662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r88">88</xref>
###xml 1663 1665 1663 1665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r89">89</xref>
###xml 2757 2759 2757 2759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r90">90</xref>
###xml 2943 2945 2943 2945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r91">91</xref>
###xml 3243 3245 3243 3245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r92">92</xref>
###xml 770 774 <span type="species:ncbi:10090">mice</span>
###xml 936 941 <span type="species:ncbi:10090">mouse</span>
###xml 1027 1031 <span type="species:ncbi:10090">mice</span>
###xml 1226 1231 <span type="species:ncbi:9606">human</span>
###xml 1385 1393 <span type="species:ncbi:9606">patients</span>
###xml 1937 1942 <span type="species:ncbi:9606">human</span>
###xml 3221 3226 <span type="species:ncbi:9606">human</span>
One role for ETS-1 and ETS-2 in ocular cancer and choroidal melanoma may be mediated through their increased transcriptional activity and upregulated expression of their target genes involved in angiogenesis and/or metastatic propagation. ETS-1 and ETS-2 are activated by phosphorylation through Ras/mitogen-activated protein kinase signaling [81] but may also be repressed by serine phosphorylation [82,83]. Active ETS proteins can transactivate targeted genes. We studied the expression of target genes encoding ICAM-1, PAI-1, MCP-1, and p16 to determine the potential roles of ETS-1 and ETS-2 in the development of this tumor. We demonstrated by semi-quantitative RT-PCR that ETS-1 and ETS-2 target genes were upregulated from P20 to the age of three months in these mice, consistent with our observations for ETS-1 and ETS-2 mRNA and protein levels. These findings strongly suggest that both ETS-1 and ETS-2 are upregulated in this mouse model of ocular tumor with higher levels of transcriptional activity than in control mice. These effects may be involved in the pathogenic mechanisms of this disease. Most ETS factors are oncogenic [17], and the upregulation of ETS gene expression has been described in many types of human tumors. The levels of expression of these genes are correlated with invasion and metastasis and may be useful for predicting tumor progression in cancer patients. ETS-1 has also been implicated in various pathways involved in tumor angiogenesis through the activation of various target genes. It is active in esophageal squamous cell carcinoma [84], testicular germ cell tumors [85], ovarian cancer [86,87], and gastric cancer [88,89]. Vascular remodeling is a key feature of all these cancers. A large body of data suggests that tumor growth involves normal and abnormal vascular processes, nourishing tumor cells, and favoring their multiplication. Therefore, it is hardly surprising that the growth of human uveal melanomas is associated with abnormal vascularization processes. An ability to form vascular loops has recently been identified as an important prognostic factor in choroidal melanoma. Tumors may develop an intricate pattern of microcirculation independent of angiogenesis. In aggressive primary and metastatic melanomas, the tumor cells generate acellular microcirculatory channels composed of extracellular matrix and lined externally by tumor cells. The de novo generation of vascular channels by aggressive and metastatic tumor cells is not strictly vasculogenic because true vasculogenesis results in the de novo formation of endothelial cell-lined vessels. This "vasculogenic mimicry" allows aggressive tumor cells to generate non-endothelial cell-lined channels delimited by the extracellular matrix [90]. These cells produce vascular endothelium-cadherin (VE-cadherin), express the vascular endothelial growth factor (VEGF) receptor, and have high levels of metalloproteinase activity [91]. The acquisition of a more classical angiogenic phenotype is also required for the malignant progression of various solid tumors. Previous studies have demonstrated that several genes including those playing an important role in angiogenesis are differentially expressed in human melanoma cells [92]. Further characterization of the molecular mechanisms and transcription factors involved in the formation of this type of tumor may lead to the development of alternative methods of inhibiting or blocking tumor growth and/or interfering with metastasis.
###end p 62
###begin p 63
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r38">38</xref>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r51">51</xref>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r93">93</xref>
###xml 834 836 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r94">94</xref>
###xml 906 908 906 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r95">95</xref>
###xml 984 986 984 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r96">96</xref>
###xml 1018 1023 1018 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PAI-1</italic>
###xml 1124 1129 1124 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PAI-1</italic>
###xml 1234 1236 1234 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r97">97</xref>
###xml 1237 1239 1237 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r98">98</xref>
ETS-1 is a critical regulator of Ang II-mediated vascular remodeling. Zhan et al. [38] identified several ETS-1 target gene products (including PAI-1 and MCP-1) involved in this pathway. PAI-1 is a major regulator of tumor invasion, metastasis, and cancer-related angiogenesis [51]. PAI-1 may interact with vitronectin, which normally promotes cell adhesion, spreading, and migration by interaction with integrins [93]. The coupling of PAI-1 to vitronectin prevents vitronectin-integrin interaction, which downregulates cell adhesion. Similarly, by competing with plasminogen activator, urokinase (uPA), the interaction of PAI-1 with vitronectin inhibits uPA-dependent cell adhesion. PAI-1 is also directly involved in tumorigenesis. Various cellular mechanisms contribute to PAI-1-regulated tumoral and choroidal neovascularization [94]. PAI-1 protects neovascularized tissues from excessive proteolysis [95] and controls in vivo tumor vascularization by interacting with proteases [96]. However, the upregulation of PAI-1 mRNA levels may be part of a mechanism to protect the cell from destruction. Indeed, high levels of PAI-1 expression are correlated with a poor prognosis in various types of cancer (gastric, breast, and lung) [97,98].
###end p 63
###begin p 64
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r50">50</xref>
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r99">99</xref>
###xml 549 552 549 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r100">100</xref>
###xml 553 556 553 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r103">103</xref>
###xml 591 594 591 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r104">104</xref>
###xml 829 832 829 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r105">105</xref>
###xml 918 921 918 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r106">106</xref>
###xml 1019 1021 1019 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r50">50</xref>
###xml 283 291 <span type="species:ncbi:9606">patients</span>
###xml 940 944 <span type="species:ncbi:10090">mice</span>
MCP-1 (or ccl2) is a chemokine that attracts and activates mononuclear cells. Many studies have shown that MCP-1 promotes tumor growth (for review see [50]). Cancer cells secrete chemokines to promote tumor growth and progression. For example, a high level of MCP-1 in breast cancer patients is associated with a significantly shorter relapse-free survival period than low levels of MCP-1 [99]. MCP-1 also seems to be involved in the recruitment of tumor-associated macrophages in several types of cancer (ovarian, gastric, breast, and esophageal) [100-103] and has pro-angiogenic activity [104]. The macrophages attracted by MCP-1 are potent sources of other angiogenic factors including VEGF. It therefore remains unclear whether the angiogenic effects of MCP-1 are direct or mediated by macrophage recruitment and activation [105]. MCP-1 seems to have a direct effect on tumors through its effects on angiogenesis [106]. MCP-1-deficient mice were shown to be protected in models of endogenous carcinoma development [50].
###end p 64
###begin p 65
###xml 239 242 239 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r107">107</xref>
###xml 372 380 372 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16INK4A</italic>
###xml 432 435 432 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 586 589 586 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r108">108</xref>
###xml 630 633 630 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 796 799 796 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 819 822 819 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r109">109</xref>
###xml 1210 1213 1210 1213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 1423 1426 1423 1426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r110">110</xref>
###xml 1449 1452 1449 1452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 1599 1602 1599 1602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 1620 1623 1620 1623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r111">111</xref>
###xml 1723 1727 1723 1727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MITF</italic>
###xml 1134 1139 <span type="species:ncbi:9606">human</span>
###xml 1219 1224 <span type="species:ncbi:10090">mouse</span>
###xml 1417 1421 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
The p16INK4A cyclin-dependent kinase inhibitor has been implicated in replicative senescence, the state of permanent growth arrest induced by cumulative cell divisions or constitutive Ras-Raf-MEK signaling in somatic cells. Ohtani et al. [107] demonstrated a role for ETS-1 and ETS-2 in the regulation of p16INK4A production involving the binding to and activation of the p16INK4A gene promoter. We observed the upregulation of the p16 gene expression in our model, consistent with the high levels of p16 detected in a rapidly growing malignant uveal melanoma in a previous case study [108]. However, other groups have found that p16 gene expression levels in melanoma cells are lower than or the same as in normal cells. Similar to our findings, a previous study demonstrated an upregulation of p16 in uveal melanoma [109]. They observed upregulation of cyclin D1, cyclin E, and p16INK4A, together with abnormal pRB and E2F binding. They concluded that the overproduction of cyclins D1 and E and Cyclin Dependant Kinases Inhibitor (CDKI) p16 together with the deregulation of the Rb/E2F pathway may be involved in the development of human uveal melanoma. Consistent with this, we observed the upregulation of p16 in a mouse model of choroidal melanoma in which tumor formation is induced by the SV-40 T antigen. The gene encoding pRb is a target of several transforming viral oncoproteins including the T antigen of SV40 [110]. The upregulation of p16 may also be due to the upregulation of the microphthalmia-associated transcription factor (MITF) transcription factor. Like ETS-1, MITF activates p16 gene expression [111]. MITF has been described as a highly sensitive immunohistochemical marker for melanoma diagnosis. MITF gene amplification is involved in melanoma progression.
###end p 65
###begin p 66
###xml 79 85 79 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ICAM-1</italic>
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r45">45</xref>
###xml 235 238 235 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r112">112</xref>
###xml 351 354 351 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r113">113</xref>
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r46">46</xref>
###xml 614 620 614 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ICAM-1</italic>
###xml 651 654 651 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r114">114</xref>
###xml 884 887 884 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r115">115</xref>
###xml 118 123 <span type="species:ncbi:10090">mouse</span>
###xml 391 396 <span type="species:ncbi:10090">mouse</span>
###xml 550 555 <span type="species:ncbi:10090">mouse</span>
We then studied the expression level of the ETS-2 target gene encoding ICAM-1. ICAM-1 mRNA levels were higher in this mouse model of choroidal melanoma than in controls. The gene encoding ICAM-1 is transactivated directly by ETS-2 [45,112]. ICAM-1 regulates cell-cell and cell-matrix adhesion, and its role in inflammation has been studied in detail [113]. Recent work based on the use of a mouse antibody against ICAM-1 has shown that blocking this adhesion molecule inhibits the growth of uveal melanoma in a severe combined immunideficient (SCID) mouse model [46]. A previous study revealed very high levels of ICAM-1 gene expression in melanomas [114]. ICAM-1 acts in association with neutrophils by inducing polymorphonuclear (PMN) cell degranulation and releasing proteases, which break down the endothelial barrier and promote tumor cell migration during metastasis formation [115]. Our data are consistent with previous findings. Thus, upregulation of the production and activity of the ETS-2 transcription factor may promote cell proliferation and metastasis in this tumor model.
###end p 66
###begin p 67
###xml 95 100 95 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-1</italic>
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ETS-2</italic>
The changes observed in expression levels of ETS target genes seem modest compared to those of ETS-1 and ETS-2. This may be due to the involvement of other transcription factors or transcription regulators possibly acting together at the promoters of these genes.
###end p 67
###begin p 68
###xml 166 169 166 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r116">116</xref>
###xml 376 379 376 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r117">117</xref>
ETS-1 and/or ETS-2 could also be involved in epithelial-mesenchyme transitions (EMT). These transitions include a variety of intercellular and intracellular changes [116]. EMT plays an important role in the development of many tissues during embryogenesis, but similar cell changes occur during pathological processes such as cancer development. ETS-1 is produced during EMT [117]. Further experiments are required to confirm the involvement of ETS-1 and ETS-2 in this process.
###end p 68
###begin p 69
###xml 759 761 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r38">38</xref>
###xml 1291 1294 1291 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r118">118</xref>
###xml 299 304 <span type="species:ncbi:10090">mouse</span>
###xml 592 597 <span type="species:ncbi:9606">human</span>
###xml 1489 1494 <span type="species:ncbi:9606">human</span>
In conclusion, this study shows that ETS-1 and ETS-2 may play a major role in choroidal melanoma. We have characterized the distribution of these two transcription factors in the normal and diseased eye. The upregulation of these proteins was correlated with upregulation of their target genes in a mouse model of ocular neoplasm. Thus, ETS-1 and ETS-2 may be involved in the development of this disease and are therefore potential targets for choroidal melanoma gene therapy. The next step could be to explore the consequences of an upregulation of these ETS transcription factors in normal human melanocytes to observe if these cells become neoplastics. Our findings are also consistent with those obtained in the ETS-1-dependent vascular remodeling model [38], which identifies ETS-1 as a direct target of Ang II in vascular remodeling mediated by MCP-1 and PAI-1. This ETS transcription factor, which increases the production of MCP-1 and PAI-1, both of which are involved in vascular remodeling, was significantly upregulated in our model. Our findings may have important implications for the development of new therapeutic agents for use in uveal melanoma. Indeed, vascular remodeling is known to be a key factor in the development of resistance to antiangiogenic treatment in tumors [118]. Future studies may confirm that vascular remodeling does indeed occur in this tumor. ETS-1 and angiotensin II receptors would thus be very important targets for cancer treatment. The study of human choroidal melanoma tumors should shed light on the role of the genes encoding ETS-1 and ETS-2 in the pathogenesis and progression of these tumors.
###end p 69
###begin title 70
Acknowledgments
###end title 70
###begin p 71
We thank the President of Retina-France, Jean-Paul Ratte, and all the members of the administrative council of Retina-France for their continuous financial and moral support. We thank Professor Jean-Louis Dufier and all members of the Scientific Advisory Board of Retina-France for their continuous support to our team. We thank the Ministry of Research of France for its continuous financial support to EA #2502. We thank Professor Axel Kahn, President of Universite Paris-Descartes for his permanent fight for the development of biomedical research in our university and in our country. We thank particularly Professor Patrick Berche, the Dean of Faculte de Medecine Paris Descartes for his help and continuous support. We thank FRM, Ligue Nationale Contre Le Cancer, ARC, Fondation de l'Avenir pour la Reherche Medicale Appliquee, Fondation de France, Association Valentin Hauy pour le Bien des Aveugles, AFM, CNG, INSERM, CNRS, ANR, Conseil Regional d'Ile de France, and Ville de Paris for the support they have provided to our team. We would particularly like to thank Professor Jean Dausset and Societe de Secours des Amis des Sciences for their crucial financial support to our Ph.D. students during a particularly difficult year.
###end p 71
###begin title 72
References
###end title 72
###begin article-title 73
DNA tumor virus transforming proteins and the cell cycle.
###end article-title 73
###begin article-title 74
###xml 27 31 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Cellular transformation by SV40 large T antigen: interaction with host proteins.
###end article-title 74
###begin article-title 75
The p53 protein and its interactions with the oncogene products of the small DNA tumor viruses.
###end article-title 75
###begin article-title 76
###xml 0 4 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene.
###end article-title 76
###begin article-title 77
###xml 33 48 <span type="species:ncbi:10633">simian virus 40</span>
Association of p300 and CBP with simian virus 40 large T antigen.
###end article-title 77
###begin article-title 78
###xml 0 4 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation.
###end article-title 78
###begin article-title 79
###xml 12 17 <span type="species:ncbi:9606">human</span>
Creation of human tumour cells with defined genetic elements.
###end article-title 79
###begin article-title 80
###xml 22 37 <span type="species:ncbi:10090">transgenic mice</span>
Malignant melanoma in transgenic mice.
###end article-title 80
###begin article-title 81
###xml 0 15 <span type="species:ncbi:10090">Transgenic mice</span>
Transgenic mice with pigmented intraocular tumors: tissue of origin and treatment.
###end article-title 81
###begin article-title 82
###xml 120 124 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 135 150 <span type="species:ncbi:10090">transgenic mice</span>
Tumors of the retinal pigment epithelium metastasize to inguinal lymph nodes and spleen in tyrosinase-related protein 1/SV40 T antigen transgenic mice.
###end article-title 82
###begin article-title 83
###xml 40 55 <span type="species:ncbi:10090">transgenic mice</span>
Melanocyte culture lines from Tyr-SV40E transgenic mice: models for the molecular genetic evolution of malignant melanoma.
###end article-title 83
###begin article-title 84
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
Genetic predisposition of transgenic mouse melanocytes to melanoma results in malignant melanoma after exposure to a low ultraviolet B intensity nontumorigenic for normal melanocytes.
###end article-title 84
###begin article-title 85
###xml 35 50 <span type="species:ncbi:10090">transgenic mice</span>
Melanosis and associated tumors in transgenic mice.
###end article-title 85
###begin article-title 86
A conserved transcriptional enhancer that specifies Tyrp1 expression to melanocytes.
###end article-title 86
###begin article-title 87
Ets target genes: past, present and future.
###end article-title 87
###begin article-title 88
The ETS-domain transcription factor family.
###end article-title 88
###begin article-title 89
###xml 54 59 <span type="species:ncbi:9606">human</span>
ETS transcription factors and their emerging roles in human cancer.
###end article-title 89
###begin article-title 90
A model for gene evolution of the ets-1/ets-2 transcription factors based on structural and functional homologies.
###end article-title 90
###begin article-title 91
Genomic dispersal of the ets gene family during metazoan evolution.
###end article-title 91
###begin article-title 92
The ets gene family.
###end article-title 92
###begin article-title 93
The biology of the Ets1 proto-oncogene.
###end article-title 93
###begin article-title 94
Expression of the ets-1 proto-oncogene in melanocytic lesions.
###end article-title 94
###begin article-title 95
c-Ets1 is a promising marker in epithelial ovarian cancer.
###end article-title 95
###begin article-title 96
Clinical implications of expression of ETS-1 related to angiogenesis in uterine cervical cancers.
###end article-title 96
###begin article-title 97
Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer.
###end article-title 97
###begin article-title 98
###xml 77 82 <span type="species:ncbi:9606">human</span>
Ets-1: a plausible marker of invasive potential and lymph node metastasis in human oral squamous cell carcinomas.
###end article-title 98
###begin article-title 99
###xml 81 89 <span type="species:ncbi:9606">patients</span>
Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer.
###end article-title 99
###begin article-title 100
###xml 33 38 <span type="species:ncbi:9606">human</span>
High expression of ets-1 gene in human thymocytes and immature T leukemic cells.
###end article-title 100
###begin article-title 101
Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential.
###end article-title 101
###begin article-title 102
Overexpression of Ets-1 transcription factor in angiosarcoma of the skin.
###end article-title 102
###begin article-title 103
Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells.
###end article-title 103
###begin article-title 104
Combinatorial function of ETS transcription factors in the developing vasculature.
###end article-title 104
###begin article-title 105
Inhibition of Angiogenesis In Vivo by ets-1 Antisense Oligonucleotides-Inhibition of Ets-1 Transcription Factor Expression by the Antibiotic Fumagillin.
###end article-title 105
###begin article-title 106
Angiogenesis inhibition by transdominant mutant Ets-1.
###end article-title 106
###begin article-title 107
###xml 90 94 <span type="species:ncbi:10090">mice</span>
The Ets-1 transcription factor is required for the development of natural killer cells in mice.
###end article-title 107
###begin article-title 108
Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene.
###end article-title 108
###begin article-title 109
Defective activation and survival of T cells lacking the Ets-1 transcription factor.
###end article-title 109
###begin article-title 110
Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling.
###end article-title 110
###begin article-title 111
The chromosome 21 transcription factor ETS2 transactivates the beta-APP promoter: implications for Down syndrome.
###end article-title 111
###begin article-title 112
Ets-2 is induced by oxidative stress and sensitizes cells to H(2)O(2)-induced apoptosis: implications for Down's syndrome.
###end article-title 112
###begin article-title 113
Overexpression of the chromosome 21 transcription factor Ets2 induces neuronal apoptosis.
###end article-title 113
###begin article-title 114
###xml 101 106 <span type="species:ncbi:9606">human</span>
Triplex DNA-mediated downregulation of Ets2 expression results in growth inhibition and apoptosis in human prostate cancer cells.
###end article-title 114
###begin article-title 115
Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer.
###end article-title 115
###begin article-title 116
ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis.
###end article-title 116
###begin article-title 117
The transcription of the intercellular adhesion molecule-1 is regulated by Ets transcription factors.
###end article-title 117
###begin article-title 118
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
Effect of an anti-CD54 (ICAM-1) monoclonal antibody (UV3) on the growth of human uveal melanoma cells transplanted heterotopically and orthotopically in SCID mice.
###end article-title 118
###begin article-title 119
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
A gene transfer comparative study of HSA-conjugated antiangiogenic factors in a transgenic mouse model of metastatic ocular cancer.
###end article-title 119
###begin article-title 120
Synthesis of digoxigenin-labeled cRNA probes for nonisotopic in situ hybridization using reverse transcription polymerase chain reaction.
###end article-title 120
###begin article-title 121
A new PCR-based approach for the preparation of RNA probe.
###end article-title 121
###begin article-title 122
CCL2 (monocyte chemoattractant protein-1) and cancer.
###end article-title 122
###begin article-title 123
Plasminogen activator inhibitor type-1: its structure, biological activity and role in tumorigenesis
###end article-title 123
###begin article-title 124
Pea3 expression is regulated by FGF signaling in developing retina.
###end article-title 124
###begin article-title 125
Expression of the ETS transcription factor ELF3 in the retinal pigment epithelium.
###end article-title 125
###begin article-title 126
Ets family transcription factor ESE-1 is expressed in corneal epithelial cells and is involved in their differentiation.
###end article-title 126
###begin article-title 127
###xml 90 100 <span type="species:ncbi:7227">Drosophila</span>
JUN cooperates with the ETS domain protein pointed to induce photoreceptor R7 fate in the Drosophila eye.
###end article-title 127
###begin article-title 128
###xml 69 79 <span type="species:ncbi:7227">Drosophila</span>
The activities of two Ets-related transcription factors required for Drosophila eye development are modulated by the Ras/MAPK pathway.
###end article-title 128
###begin article-title 129
The ETS domain protein pointed-P2 is a target of MAP kinase in the sevenless signal transduction pathway.
###end article-title 129
###begin article-title 130
###xml 57 62 <span type="species:ncbi:9606">human</span>
Characterization and localization of the products of the human homologs of the v-ets oncogene.
###end article-title 130
###begin article-title 131
###xml 66 72 <span type="species:ncbi:10090">murine</span>
Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis.
###end article-title 131
###begin article-title 132
The diverse role of the ETS family of transcription factors in cancer.
###end article-title 132
###begin article-title 133
ETS transcription factors: possible targets for cancer therapy.
###end article-title 133
###begin article-title 134
The Ets transcription factor GABP is required for cell-cycle progression.
###end article-title 134
###begin article-title 135
###xml 0 15 <span type="species:ncbi:10633">Simian virus 40</span>
###xml 116 119 <span type="species:ncbi:10116">rat</span>
Simian virus 40 large T antigen contains two independent activities that cooperate with a ras oncogene to transform rat embryo fibroblasts.
###end article-title 135
###begin article-title 136
###xml 45 49 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Inhibition of Rb and p53 is insufficient for SV40 T-antigen transformation.
###end article-title 136
###begin article-title 137
###xml 54 58 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Involvement of chromatin and histone deacetylation in SV40 T antigen transcription regulation.
###end article-title 137
###begin article-title 138
###xml 47 52 <span type="species:ncbi:9606">human</span>
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells.
###end article-title 138
###begin article-title 139
Gene silencing in cancer in association with promoter hypermethylation.
###end article-title 139
###begin article-title 140
###xml 77 82 <span type="species:ncbi:9606">human</span>
DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
###end article-title 140
###begin article-title 141
The role of DNA methylation in cancer development.
###end article-title 141
###begin article-title 142
Histone tail modifications and noncanonical functions of histones: perspectives in cancer epigenetics.
###end article-title 142
###begin article-title 143
Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas.
###end article-title 143
###begin article-title 144
Multidrug resistance in uveal melanoma.
###end article-title 144
###begin article-title 145
###xml 64 69 <span type="species:ncbi:9606">human</span>
###xml 103 108 <span type="species:ncbi:10090">mouse</span>
Characterization of the typical multidrug resistance profile in human uveal melanoma cell lines and in mouse liver metastasis derivatives.
###end article-title 145
###begin article-title 146
MicroRNA expression in colon adenocarcinoma.
###end article-title 146
###begin article-title 147
MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.
###end article-title 147
###begin article-title 148
###xml 80 85 <span type="species:ncbi:9606">human</span>
Reduction of PKC alpha decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma.
###end article-title 148
###begin article-title 149
###xml 128 134 <span type="species:ncbi:10090">murine</span>
Inhibition of PKCalpha decreases the gelatinase activity and the angiogenic and metastatic ability of the highly metastatic B16 murine melanoma cells.
###end article-title 149
###begin article-title 150
Protein kinase Calpha plays a critical role in mannosylerythritol lipid-induced differentiation of melanoma B16 cells.
###end article-title 150
###begin article-title 151
###xml 88 94 <span type="species:ncbi:10090">murine</span>
Photo-induced inactivation of protein kinase calpha by dequalinium inhibits motility of murine melanoma cells.
###end article-title 151
###begin article-title 152
Ets1 is an effector of protein kinase Calpha in cancer cells.
###end article-title 152
###begin article-title 153
Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment.
###end article-title 153
###begin article-title 154
Variable control of Ets-1 DNA binding by multiple phosphates in an unstructured region.
###end article-title 154
###begin article-title 155
Phosphorylation represses Ets-1 DNA binding by reinforcing autoinhibition.
###end article-title 155
###begin article-title 156
###xml 89 96 <span type="species:ncbi:9606">patient</span>
Ets-1 and VEGF expression correlates with tumor angiogenesis, lymph node metastasis, and patient survival in esophageal squamous cell carcinoma.
###end article-title 156
###begin article-title 157
Angiogenetic protooncogene ets-1 induced neovascularization is involved in the metastatic process of testicular germ cell tumors.
###end article-title 157
###begin article-title 158
Clinical implications of expression of ETS-1 in relation to angiogenesis in ovarian cancers.
###end article-title 158
###begin article-title 159
Clinical implications of expression of ETS-1 related to angiogenesis in metastatic lesions of ovarian cancers.
###end article-title 159
###begin article-title 160
Ets-1 expression in gastric cancer.
###end article-title 160
###begin article-title 161
Expression of Ets-1 angiogenesis-related protein in gastric cancer.
###end article-title 161
###begin article-title 162
Vasculogenic mimicry and tumor angiogenesis.
###end article-title 162
###begin article-title 163
###xml 68 73 <span type="species:ncbi:9606">human</span>
Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry.
###end article-title 163
###begin article-title 164
Vitronectin.
###end article-title 164
###begin article-title 165
Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I.
###end article-title 165
###begin article-title 166
In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis.
###end article-title 166
###begin article-title 167
The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies.
###end article-title 167
###begin article-title 168
Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer.
###end article-title 168
###begin article-title 169
###xml 73 78 <span type="species:ncbi:9606">human</span>
Urokinase and tissue plasminogen activators and their inhibitor PAI-1 in human tumors.
###end article-title 169
###begin article-title 170
###xml 110 115 <span type="species:ncbi:9606">human</span>
Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.
###end article-title 170
###begin article-title 171
Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines.
###end article-title 171
###begin article-title 172
Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma.
###end article-title 172
###begin article-title 173
###xml 111 116 <span type="species:ncbi:9606">human</span>
Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human gastric carcinomas.
###end article-title 173
###begin article-title 174
###xml 111 116 <span type="species:ncbi:9606">human</span>
Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas.
###end article-title 174
###begin article-title 175
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression.
###end article-title 175
###begin article-title 176
Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1.
###end article-title 176
###begin article-title 177
CCL2 regulates angiogenesis via activation of Ets-1 transcription factor.
###end article-title 177
###begin article-title 178
Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence.
###end article-title 178
###begin article-title 179
Expression of cell cycle related proteins in a rapidly growing uveal malignant melanoma.
###end article-title 179
###begin article-title 180
###xml 42 47 <span type="species:ncbi:9606">human</span>
Abnormal cell cycle regulation in primary human uveal melanoma cultures.
###end article-title 180
###begin article-title 181
Cellular proteins that are targetted by DNA tumor viruses for transformation.
###end article-title 181
###begin article-title 182
MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A.
###end article-title 182
###begin article-title 183
###xml 62 67 <span type="species:ncbi:9606">human</span>
Intercellular adhesion molecule-1 (ICAM-1) gene expression in human T cells is regulated by phosphotyrosyl phosphatase activity. Involvement of NF-kappaB, Ets, and palindromic interferon-gamma-responsive element-binding sites.
###end article-title 183
###begin article-title 184
Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1).
###end article-title 184
###begin article-title 185
De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis.
###end article-title 185
###begin article-title 186
ICAM-1-CD18 interaction mediates neutrophil cytotoxicity through protease release.
###end article-title 186
###begin article-title 187
Complex networks orchestrate epithelial-mesenchymal transitions.
###end article-title 187
###begin article-title 188
###xml 92 97 <span type="species:ncbi:9031">chick</span>
The ETS1 transcription factor is expressed during epithelial-mesenchymal transitions in the chick embryo and is activated in scatter factor-stimulated MDCK epithelial cells.
###end article-title 188
###begin article-title 189
Vascular remodeling and clinical resistance to antiangiogenic cancer therapy.
###end article-title 189

